Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1425
+0.0025 (1.79%)
At close: Aug 26, 2026

XSAT:ISAB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8.33.0411.0517.512.199.42
Revenue Growth
54.96%-72.47%-36.89%43.55%29.42%-7.05%
Gross Profit
5.332.5910.1113.969.645.22
Operating Income
-8.57-10.16-5.08-3.76-12.03-16.57
Net Income
-8.56-10.16-5.15-4.74-12.13-16.61
Earnings Per Share
-0.20-0.35-0.34-0.36-1.07-1.64
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.72.834.457.831.8414.4
Total Debt
--0.441.091.341.85
Net Cash (Debt)
1.72.8346.740.512.55
Net Cash Growth
-82.47%-29.28%-40.56%1244.31%-96.01%116.31%
Net Cash Per Share
0.040.100.260.510.041.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.86-10.79-2.94-3.74-12.01-18.74
Capital Expenditures
-----0.04-0.15
Free Cash Flow
-9.86-10.79-2.94-3.74-12.05-18.89
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.20%85.00%91.52%79.77%79.08%55.40%
Operating Margin
-103.23%-333.94%-45.95%-21.46%-98.61%-175.88%
Pretax Margin
-103.11%-334.10%-46.59%-27.10%-99.43%-176.28%
Profit Margin
-103.11%-334.10%-46.59%-27.10%-99.43%-176.28%
FCF Margin
-118.84%-354.69%-26.59%-21.38%-98.79%-200.52%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.8855.905.963.504.5312.32